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Abstract
Background: Borrelia burgdorferi sensu lato and Anaplasma phagocytophilum are able to infect horses. However,
the extend to which Danish horses are infected and seroconvert due to these two bacteria is unknown. The aim of
the present study was to evaluate the seroprevalence of B. burgdorferi sensu lato and A. phagocytophilum in Danish
horses.
Methods: A total of 390 blood samples collected from all major regions of Denmark and with a geographical
distribution corresponding to the density of the Danish horse population were analyzed. All samples were
examined for the presence of antibodies against B. burgdorferi sensu lato and A. phagocytophilum by the use of the
SNAP®4DX ® ELISA test.
Results: Overall, 29.0% of the horses were seropositive for B. burgdorferi sensu lato whereas 22.3% were
seropositive for A. phagocytophilum.
Conclusions: Antibodies against B burgdorferi sensu lato and A. phagocytophilum are commonly found among
Danish horses thus showing that Danish horses are frequently infected by these organisms.
Background
The vector-borne bacteria Borrelia burgdorferi sensu
lato (B. burgdorferi s. l.) and Anaplasma phagocytophi-
lum infect horses in those parts of the world where
Ixodes spp. are present. It has been estimated that up to
30-40% of horses in an endemic area are seropositive
for B. burgdorferi s. l. [1]. Most of these horses will
remain asymptomatic, while 5-10% of them are likely of
developing clinical signs [1-4]. Similar, a previous study
on A. phagocytophilum, have indicated that up to 50%
of seropositive horses in endemic areas undergo a sub-
clinical infection [5]. It is assumed that clinical equine
granulocytic anaplasmosis is an overseen condition in
most of Europe, as most horses recover spontaneously
and therefore do not attract the attention of clinicians
[6]. In Denmark, B. burgdorferi s. l. and A. phagocytophi-
lum a r et r a n s f e r r e db yt h et i c kIxodes ricinus.AD a n i s h
study from 2005 revealed that the tick density varies
substantially between different regions of Denmark with
highest density on the island of Bornholm (0.5-1.0 ticks/
min. flagging) followed by Zealand, Funen, Middle-Jut-
land and East-Jutland (0.25-0.5 ticks/min. flagging),
South-Jutland (0.15-0.25 ticks/min. flagging), and West
and North-Jutland (0-0.15 ticks/min. flagging) [7]. An
apparent increase in the tick density from 1984 to 1998
[8] fits well with a positively correlated relationship
between warmer winters and longer spring and autumn
periods and the density of I. ricinus [9,10].
T h es e r o p r e v a l e n c eo fB. burgdorferi s. l. and A. pha-
gocytophilum among horses in Denmark has to our
knowledge never been evaluated. Recent European stu-
dies on the seroprevalence of B. burgdorferi s. l. shows a
prevalence of 47.8% seropositive horses in Slovakia [11],
25.6% in Poland [12], 16.8% in Sweden [13], 16.1% in
Germany [14] and 6.3% in Turkey [15]. The seropreva-
lence of A. phagocytophilum in Europe varies from
83.3% in Holland [6], 16.7% in Sweden [13], 11.3% in
France [16], 8.1% in Italy [17,18] to 6.5% in Spain [19].
Furthermore, a Swedish study reported that 4.5% of the
examined horses were seropositive for both B.
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Danish researchers made a seroprevalence study on the
distribution of B. burgdorferi s. l. and A. phagocytophi-
lum antibodies in Danish deer. The overall seropreva-
lence was 36.6% for B. burgdorferi s. l. Significant
regional differences were found when Jutland was com-
pared with the islands (Funen, Zealand, Lolland, Falster
and Bornholm) with a seroprevalence of 27.1% versus
46.7%, respectively. In the case of A. phagocytophilum,
all tested deer in three districts of North-Jutland were
antibody negative although the average seroprevalence
was found to be 42.6% ranging from 39.6% in Jutland to
47.6% of the islands [7].
The aim of the present study was to evaluate the sero-
prevalence of B. burgdorferi s. l. and A. phagocytophilum
in Danish horses.
Materials and methods
Sample size
The sample size was calculated using the following for-
mulas:
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where n is the sample size, E is the margin of error, r
is the fraction of response that we are interested in and
Z c () 100 is the critical value for the confidence level of c.
As the prevalence of horses seropositive for B. burg-
dorferi s. l. and A. phagocytophilum vary considerably in
areas comparable to Denmark [11-14], calculations were
b a s e do nas i t u a t i o nw h e r et h et e s tr e s u l t sf r o me a c h
individual horse could have 50%-50% test outcome (r=
50%). A difference of more than 5% (E) to the expected
50%-50% outcome with ac o n f i d e n c eo f9 5 %( c) should
be detected. Thus, with an estimated population of
200,000 horses (N) in Denmark, a sample size including
384 individuals was proposed. As the test kits came as
pre-packed batches, 390 individual blood samples were
taken.
Selection of horses
No formal randomized selection of horses was applied
but an even representation of samples from all regions
in Denmark was aimed at. Denmark is officially divided
into five administrative regions including the Capital
Region (C), Region Zealand (Z), Region South-Denmark
(SD), Region Central-Jutland (CJ) and Region North-Jut-
land (NJ) (Figure 1). Assuming that the horse population
is evenly distributed between the five regions, a sample
size of 78 horses was used for each region. Within each
region, horses were selected based on availability due to
previous contact to individual horse owners, horse studs
and clinical veterinary practices. Approximately one
third of the samples were obtained from horses
admitted to four equine veterinary clinics. The remain-
ing samples were taken during visits to various size
breeding farms, horse riding schools and farms. No
horses with signs or a recent history of untreated infec-
tious diseases were included.
Serological evaluation of blood samples
A total of 390 blood samples were collected in EDTA
blood collection tubes. All blood samples were analyzed
immediately by a SNAP®4DX ® ELISA test (IDEXX
Laboratories, Taastrup, Denmark) according to the man-
ufactures instructions.
Putative risk factors
Every horse owner was asked to provide information with
regard to putative risk factors including the breed, gen-
der, age, use and housing, respectively. For each factor, 2-
5 categories were established; “no answer” was included
as a category. Gender included mare, stallion and gelding.
Age was classified into groups of 1-4 years, 5-10 years,
11-20 years, and over 21 years. Housing facilities
included pasture and pasture in combination with stabled
housing, and access to pasture in the summer period was
categorized as 1-3 months and >3 months. The horses
were used for breeding, competitions/races, riding school
and for leisure riding. Another risk factor was the use of
the horse; it included the categories not used for riding,
primarily used for leisure riding in the terrain or primar-
ily used on a riding ground. Finally it was noted if the
horse has been used for breeding.
Statistical analyses
The ELISA results and their association with the puta-
tive risk factors were statistically analyzed using the
PROC logistic procedure in SAS 9.1 (SAS Institute,
Cary, NC, USA). A logit-transformation was used to
estimate the relation between the outcome and the
explanatory variables.
The model was given by:
Logit (pi)=a + b(bacteriai)+c ( r e g i o n i)+ d(genderi)+
e(agei)+f ( h o u s i n g i) + g(pasture in summer periodi)+ h
(breedi) + i(usei) + j(riding typei) + k(breedingi)
Where Pi is the dependent variable thefollowing out-
comes was possible i) B. burgdorferi s. l. ii) A. phagocyto-
philum, iii) B. burgdorferi s. l. or A. phagocytophilum iv)
both B. burgdorferi s. l. and A. phagocytophilum), a is
the intercept, and irefers to the level of categories to the
respective risk factor. The PROC logistic procedure
tested two-way interactions between the different expla-
natory variables (risk factors). From the full model
including all explanatory variables, a backward elimina-
tion was used to exclude non-significant variables. The
parametric statistical Wald test was used to exclude the
most non-significant variables until all variables in the
model were significant.
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B. burgdorferi s. l., A. phagocytophilum and the different
regions, Chi square test or Fischer’se x a c tt e s tw e r e
used.
All statistical calculations were made with the software
SAS 9.1. The level of significance was set to P < 0.05.
Results
Sampling
The sampled horses consisted of 222 mares, 135 geld-
ings and 33 stallions. The breeds included Icelandic
horse (182), Danish Warmblood (67), Jysk horse (11),
Standardbred (11), Shetland Pony (10), Oldenburg (6),
Friesian (6), Trakehner (5), Hanoverian (5), North Bagge
(5), Connemara (4), Arabs (4) and other/mixed breeds
(74). Horses aged 1 to 30 years (Mean = 9.2 years, SD ±
6.0) were included. All samples were obtained in the
period from the 5
th of April to the 11
th of May 2009.
The horses sampled originated from herds based in 42
individual postal codes (Figure 1). Of the horses tested
through the participating veterinary clinics, 6-8 were
under treatment and in the late recovery phase of an
antibiotic treatment regimen, whereas the remaining
horses were prophylactic cases including vaccination,
teeth management, and the vast majority were subjected
to assisted reproduction.
Serology
The over-all seroprevalence of B. burgdorferi s. l. was
29.0% and 22.3% for A. phagocytophilum. The highest
seroprevalence of 33.3% for B. burgdorferi s. l. was
found in the Region of South-Denmark while only
24.4% of the samples from Region of North-Jutland
were positive. The highest A. phagocytophilum seropre-
valence (33.3%) was found in the Region of Zealand
while the lowest (16.7%) was found in the Capital
Region. Despite the seemingly high regional differences
in seroprevalence for either organism, this could not be
demonstrated statistically (P ≥ 0.29). The regional sero-
prevalence distribution is summarized in Table 1.
NJ
MJ
SJ
Z
C
C
Bornholm
Figure 1 Geographical location of sample sites (stars) within each of the five administrative regions of Denmark. (NJ) Northern Jutland,
(MJ) Mid Jutland, (SJ) Southern Jutland, (Z) Zeeland and (C) Capital region.
Table 1 Seroprevalence of Borrelia burgdorferi sensu lato
and Anaplasma phagocytophilum in 390 Danish horses.
Region Borrelia-positive (%) Anaplasma-positive
(%)
Region North-Jutland 19 (24.4) 18 (23.1)
Region Central-Jutland 21 (26.9) 16 (20.5)
Region South-Denmark 26 (33.3) 14 (18.0)
Region Zealand 25 (32.1) 26 (33.3)
Capital Region 22 (28.2) 13 (16.7)
Denmark (Total) 113 (29.0) 87 (22.3)
A total of 78 horses were sampled from each region.
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the seroprevalences e.g. the Capital Region, which had
an overall low seroprevalence for both B. burgdorferi s.
l. and A. phagocytophilum. However, the seroprevalence
for the island Bornholm, which belongs to the Capital
Region was 60% for B. burgdorferi s. l. and 50% for A.
phagocytophilum. Omitting the results from Bornholm,
the Capital Region had a seroprevalence of 17.2% for B.
burgdorferi s. l. and 5.2% for A. phagocytophilum.T h e r e
was a significant lower seroprevalence of both B. burg-
dorferi s. l. (P = 0.017) and Anaplasma phagocytophilum
(P < 0.001) in the Capital Region (Bornholm excluded)
compared to Bornholm.
No significant association was found between any of
the proposed risk factors and the occurrence of antibo-
dies against B. burgdorferi s. l. (outcome (i). On the con-
trary, a significant correlation (P ≤ 0.03) was found
between the age of the horses and the presence of A.
phagocytophilum antibodies (outcome ii). Horses aged
11 to 20 years had an odds ratio (OR) of 2.3 (with a
95% confidence interval of 1.2-4.6) for being seropositive
for A. phagocytophilum whereas horses ≥ 21 years had
an OR of 3.3 (with a 95% confidence interval 1.1-10.5)
for being seropositive compared with horses aged 1-4
years, respectively. There was no significant association
between other risk factors and presence of A. phagocyto-
philum antibodies. Eleven percent of the examined
horses were seropositive for both B. burgdorferi s. l. and
A. phagocytophilum. It appeared that the OR for horses
seropositive for B. burgdorferi s. l. was 3.1 (with a 95%
confidence interval of 1.9-5.0) when simultaneously
being seropositive for A. phagocytophilum (outcome iii).
Likewise, the OR for horses seropositive for A. phagocy-
tophilum was 3.3 (with a confidence interval of 1.9-5.4)
for simultaneously being seropositive for B. burgdorferi
s. l. (outcome iii) Thus, there was a significant associa-
tion between the occurrence of antibodies against B.
burgdorferi s. l. and A. phagocytophilum (P ≤ 0.0001)
(outcome iiii) There was no significant association
between the other factors investigated and the occur-
rence of a simultaneous infection with B. burgdorferi s.
l. and A. phagocytophilum.
Discussion
Comparing the seroprevalences of B. burgdorferi s. l. and
A. phagocytophilum with results from neighboring Eur-
opean countries [insert refs], the seroprevalences found
in this study are considerably higher. One important
point explaining this difference could relate to sampling
bias i.e. horses included in our study could have had a
higher exposure risk to infected ticks than the general
population. Although a formal randomized selection of
horses was not applied, the considerable differences in
geographic location, breed, age and use of the horses
s a m p l e di sb e l i e v e dt op r o v i d eag o o da p p r o x i m a t i o no f
the general horse population in Denmark. Furthermore,
none of the horses included this study were selected
because they exhibited or have had clinical signs of
equine borreliosis or equine granulocytic anaplasmosis.
On the contrary, previous studies have shown a steady
increase in the ticks density, which has been attributed
to climatic changes [8] and an increased infection rate
among the ticks [21], which may prove to be more likely
reasons for the higher prevalences observed. Whether
the differences in the prevalences in Denmark versus
Sweden and Germany [13,14] are due to an increase in
the number of infected ticks since the latter investiga-
tions were performed, or whether the prevalence in
Denmark in fact is higher will however remain unknown
until data from prevalence studies with a comparable
design and method from all countries in the region are
performed. Differences in study design e.g. serological
test method and statistical approach for the analysis of
the results currently makes comparison of previous
results difficult.
The highest density of ticks has previously been found
on Bornholm, whereas a lower density was observed in
the major Danish islands and in Jutland [7]. In addition
to this, a Danish study of the seroprevalence of B. burg-
dorferi s. l. in deer showed that the risk of becoming
infested with a tick positive for B. burgdorferi s. l. was
greatest in the Capital Region followed by the Region of
Zealand and the regions of Jutland, respectively. Inter-
estingly, the risk of a deer being positive for B. burgdor-
feri s. l. antibodies was two times higher for Bornholm
(part of the Capital Region) than for the island Zealand
in general [22]. The present study shows that most of
the horses seropositive for B. burgdorferi s. l. were
found in the Region of South-Denmark followed by the
Region of Zealand, the Capital Region, and Region of
Central-Jutland and the Region of North-Jutland,
thereby largely reflecting the tick density. In cases where
the results did not match the deer study [ref], this may
reflect differences as to the locality sampled within the
regions compared. In accordance with the above, the
study also shows that the prevalence of horses seroposi-
tive for B. burgdorferi s. l. on the island of Bornholm
was two times higher than for Zealand, when the results
for Bornholm was omitted in the overall result of the
Capital Region and the Region of Zealand. We analyzed
blood samples taken during spring, which likely influ-
enced the number of seropositive individuals negatively
as the likelihood of becoming seropositive later during
the summer and autumn due to a longer exposure and
risk of being infested by an infected tick [13].
The SNAP®4DX ® test was developed for screening of
Dirofilaria immitis antigen and antibodies to A. phago-
cytophilum, B. burgdorferi and Ehrlichia canis in canine
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SNAP®4DX ® has previously been evaluated and found
useful to detect antibodies against B. burgdorferi s. l.
and A. phagocytophilum in equine samples [23]. Com-
pared to Western immunoblot, the SNAP®4DX ® was
found to have a sensitivity of 100% and a specificity of
95% for detection of antibodies against B. burgdorferi s.
l. in equine samples. Detecting A. phagocytophilum anti-
bodies in equines by the SNAP® 4DX ® test comparison
to the indirect immunofluorescence assay showed a sen-
sitivity and a specificity of 100% [25]. Johnson et al. [ref]
found the SNAP®4DX ® test less sensitive (63%) yet 100%
specific when comparing it to Western blotting and a
C6-ELISA during a longer course of experimental infec-
tion [28]. By using ELISA in the form of a SNAP®4DX®
test it should be noted that this method detects both
active and previous infections with measurable antibody
levels [20]. From previous studies, the antibody levels in
horses have been found detectable for up to 2 years
[20,26]. In these, the clinically affected horses had the
highest ELISA titers compared to horses with subclinical
infections [1]. From studies with horses experimentally
infected with B. burgdorferi s. l. and subsequently ana-
lyzed by ELISA, it appeared that even in cases where
the horses had no clinical signs, antibodies were
detected within 5-6 weeks. Antibody levels rose to a
maximum over the following 3-4 months after which
they remained static for at least 9 months [27]. How-
ever, another study has shown that individual horses,
despite being positive by PCR and cell culture, did not
remain seropositive by the SNAP®4DX® test over a per-
iod of 9 months [28]. The above indicates that the anti-
body level may be detectable by some ELISA tests at
least 9 months post-infection with B. burgdorferi s. l.
but presumably for a shorter period using the
SNAP®4DX® test. Experimental infections in horses
inoculated intravenously with A. phagocytophilum
resulted in seroconversion 6-8 days post inoculation and
achieved a maximum ELISA titer at day 10-30. The
antibodies remained detectable for up to 5 months [28].
It is well established that horses acquiring a natural
infection with A. phagocytophilum mount a slower anti-
body response, likely since the burden of infection typi-
cally is lower and delivered over a prolonged period
[29]. Despite a longer incubation period, prior serocon-
version from a natural infection versus the intravenously
administered infections, the antibody levels were similar
after 30 days [30]. Therefore, it is reasonable to assume
that an ELISA may have a positive outcome for up to 5
months post-infection with A. phagocytophilum. The
results found in this study therefore likely reflect the
proportion of horses that have been infected with B.
burgdorferi s. l. within the last 9 months or A. phagocy-
tophilum w i t h i nt h el a s t5m o n t h sf r o mt h et i m eo f
sampling and not only horses with an active infection at
the time of blood sampling.
Conclusions
The present study demonstrates that antibodies against
B. burgdorferi s. l. and A. phagocytophilum can be com-
monly found in Danish horses. The findings warrant
further attention to these infections in horses particu-
larly with regard to improved means for detection of
active infections, which may contribute to a better gen-
eral understanding of these diseases and their impact on
horse behavior and welfare.
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